Preliminary Program
Preliminary Program: MONDAY MAY 22
Psychiatric News
Volume 41 Number 4 page 14-28


Industry-Supported Breakfast Symposia

IS26. Clinical Implications of Choices of Atypical Antipsychotics: Realities and Myths (Part 1)Supported by Bristol-Myers Squibb Co.

IS27. Evidence, Outcomes, and Advocacy: Shaping the Management of GAD (Part 1)Supported by Cephalon Inc.

IS28. Attaining and Sustaining Remission in Treatment of Depression With Comorbid or Residual Anxiety (Part 1)Supported by Wyeth Pharmaceuticals


Residents Session

Meet the Experts: Sunny-Side Up


Registration/Course Enrollment Open


CME Courses 38-43


CME Course 44



Clinical Case Conferences



1. Resolved: Does CATIE Really Inform the Practice of Psychotherapy?Moderator: Richard E. D'Alli, M.D.


Discussion Groups

Focus Live Session 1.Presenter: Glen O. Gabbard, M.D., on Personality Disorders



L2. Culture, Spirituality, and Psychiatry: A Psycho-Historical Study of King SaulAlbert C. Gaw, M.D., APA's Kun-Po Soo Award Lecture

L3. Rediscovering Our Place in the WorldDavid T. Suzuki, Ph.D., Frontiers of Science Lecture Series

L4. The Search for Quality and Equity in Care for Psychiatric Disorders: A Story of Opportunity, Evidence, and PartnersKenneth B. Wells, M.D., APA's Research in Psychiatry Award Lecture


Master Educator Clinical Consultations

New Research Young Investigators' Poster Session 1


Component Workshops

CW1. Disaster Psychiatry: Practical Skills to Help District Branches Develop Disaster Plans for Their CommunitiesAPA Committee on Psychiatric Dimensions of Disasters; Co-Chairpersons: Lisa A. Catapano, M.D., Christina V. Mangurian, M.D.

CW2. Pay for Performance: Linking Incentives to Provider Performance on Quality MeasuresAPA Council on Quality Care and APA Council on Healthcare Systems and Financing; Co-Chairpersons: Richard C. Hermann, M.D., Bruce J. Schwartz, M.D.

CW3. Career Choices in Psychiatry: Exploring Fellowship TrainingAPA Assembly Committee of Area Member-in-Training Representatives; Chairperson: Vincent J. Blanch, M.D.

CW4. Severely Mentally Ill Persons in Jails and Prisons: Who Should Stay?APA Corresponding Committee on Jails and Prisons; Chairperson: Henry C. Weinstein, M.D.

CW5. Crime and Cruel, Not Unusual Punishment: The Need for Juvenile Justice Mental Health Care ReformAPA Alliance; Chairperson: Louis J. Kraus, M.D.

CW6. Closing a Practice: What Every Psychiatrist's Office and Their Family Should KnowAPA Corresponding Committee on Physician Health, Illness, and Impairment; Chairperson: John A. Fromson, M.D.

CW7. Conquering the Shame, Secrecy, and Stigma of Suicide in Young Asian-American AdultsAPA Committee of Asian-American Psychiatrists; Chairperson: Surinder S. Nand, M.D.

CW8. CPT Coding and Documentation UpdateAPA Committee on RBRVS, Codes, and Reimbursements; Chairperson: Chester W. Schmidt Jr., M.D.

CW9. New Developments in APA Practice Guidelines on Bipolar Disorder, MDD, and Panic DisorderAPA Steering Committee on Practice Guidelines; Chairperson: Jack S. McIntyre, M.D.


Issue Workshops

IW1. A Dimension of Mind: Simulations/Emulations of Psychiatric Symptoms Using the Performing Art of MagicChairperson: Bruce C. Ballon, M.D.

IW2. What Do You Do With a Patient Who Has Access to a Gun?Chairperson: Donna M. Norris, M.D.

IW3. Managing Complex Comorbid Psychiatric and Alcohol Use Disorders in Psychiatric PracticeCollaborative Session With the National Institute on Alcohol Abuse and Alcoholism; Chairperson: Mark L. Willenbring, M.D.

IW4. Extrapyramidal Side Effects and Tardive Dyskinesia in the Atypical Antipsychotic EraChairperson: Thomas E. Hansen, M.D.

IW5. Neurocybernetics: Novel Approach in the Treatment of Psychiatric Disorders Chairperson: Alan L. Summers, M.D.

IW6. Treatment of Pregnancy-Related Mood Disorders: From Psychiatry to PediatricsCo-Chairpersons: Janet A. Martin, M.D., Syed S. A. Naqvi, M.D.

IW7. Risk Management Issues in Psychiatric PracticeChairperson: Alan I. Levenson, M.D.

IW8. But Can We Do It Here? Challenges of Implementing Cognitive-Behavior Therapy for Schizophrenia Programs in the U.S.Co-Chairpersons: Page Burkholder, M.D., Peter J. Weiden, M.D.

IW9. Religious and Spiritual Assessment in Clinical PracticeCo-Chairpersons: Francis G. Lu, M.D., Christina M. Puchalski, M.D.

IW10. Early Detection and Treatment of Bipolar IllnessChairperson: Eric R Marcus, M.D.

IW11. What Is a Mood Stabilizer?Chairperson: Eduard Vieta, M.D.

IW12. Reinventing Careers: Transitions and Later-Life Strategies for PsychiatristsCo-Chairpersons: Carolyn B. Robinowitz, M.D., Abram M. Hostetter, M.D.

IW13. American Board of Psychiatry and Neurology Update: Certification and Maintenance of Certification in Psychiatry and Its SubspecialtiesChairperson: Stephen C. Scheiber, M.D.

IW14. New Research Advances in EthnopsychopharmacologyCo-Chairpersons: Pedro Ruiz, M.D., William B. Lawson, M.D.

IW15. Online Peer Support Groups and Support Group MembersChairperson: Robert C. Hsiung, M.D.



Media Workshops

MW1."Go": A Triple-Take in the World of DrugsCo-Chairpersons: Petros Levounis, M.D., Jose P. Vito, M.D.

MW2. "Do I Look Fat?"Eating Disorder Pathology in Gay MenChairperson: Daniel Garza, M.D.


CME Courses 45-50



Exhibits Open

APA Member Center Open Publishers' Bookfair Open



Discussion Groups

5. Jack Drescher, M.D., on The Psychology of the Closet

6. Nathan Strahl, M.D., on TBD (Meet the Authors)

7. John Oldham, M.D., on TBD

8. Ashwin Patkar, M.D., on TBD

9. Marian I. Butterfield, M.D., on Challenges Unique to Women Psychiatrists (for residents only)

Focus Live Session 2.Presenters: Joel Yager, M.D., and Stephen B. Levine, M.D., on Eating Disorders and Sexual Disorders



L5.TBDPedro L. Delgado, M.D., APA's Simon Bolivar Award Lecture

L6. Emotional Processing and Schizophrenia: Neuropsychiatric PerspectivesRaquel Gur, M.D., Distinguished Psychiatrist

L7.The Discourse on Human Sexuality and AIDSAnke Ehrhardt, Ph.D., Frontiers of Science Lecture Series


Master Educator Clinical Consultations

4. Shaila Misri, M.D., on Perinatal Psychiatric Disorders on Current Issues in Pregnant and Postpartum Mothers (for APA members only)

5. Marion Goldstein, M.D., on Late Life Aging Processes and Mental Illness (for APA members only)

6. David Baron, D.O., Geetha Jayaram, M.D., on Clinical Research Across Geographic Borders: Challenges and Opportunities (for APA members only)

Medical Update 1.Heather Ross, M.D., on Congestive Heart Failure

Research Consultation 1.Mark L. Willenbring, M.D., on Clinical Research on Alcohol Use Disorders Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism


Scientific and Clinical Reports


Session 1. Presidential Theme: From Science to Public Policy: Advocacy for Patients and the Profession

1. The Impact of an Integrated Community Arts Studio on Stigmatizing Beliefs and Experiences Thomas C. Zelnik, M.D.

2. Health Policies and the Diagnostic and Statistical Manual Roger Peele, M.D.

3. The System for Classification of Inpatient Psychiatry: A New Case-Mix Methodology for Mental Health John P. Hirdes, Ph.D.


Session 2. Ethics and Human Rights

4. Ethics and Psychobiological Research Cherise Rosen, Ph.D.

5. Terrorism and Medical Ethics: Conflicting Loyalties for American Psychiatrists David A. Rothstein, M.D.

6. A New Mental Health Act: An Australian Experience Darryl P. Watson, M.D.


Session 3. Attention Spectrum Disorders

7. Transdermal Methylphenidate Versus Placebo in Pediatric ADHD Robert L. Findling, M.D.

8. Effects of Transdermal Methylphenidate in a Laboratory Classroom Study James J. McGough, M.D.

9. Modafinil-ADHD: Long-Term Efficacy and Safety in Children and Adolescents With ADHD Samuel W. Boellner, M.D.


Session 4. Current Trends in Schizophrenia

10. Recurring Psychosis in Schizophrenia: A 20-Year Multi, Follow-Up Study Martin Harrow, Ph.D.

11. Identifying the Neurobiological Basis for Schizophrenia Zeinab S. Elbaz, M.D.

12. Key Findings From the Intercontinental Schizophrenia Outpatients Health Outcomes Study (IC-SOHO): Disease Burden and Clinical Outcomes Associated With Antipsychotic Treatment for Schizophrenia Martin Dossenbach


Session 5. Medication Response in MDD

13. Duloxetine Versus Escitalopram and Placebo in the Long-Term Treatment of Patients With MDD Teresa A. Pigott, M.D.

14. Conditional Probability of Response to Placebo in MDD Jennifer Covino, M.P.A.

15. Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study David Michelson, M.D.


Session 6. Treatment Management and Outcomes in Mood Disorders

16. Management of Side Effects Associated With New Treatments for Bipolar Depression Joseph R. Calabrese, M.D.

17. Treatment-Resistant Depression: Changes in Symptoms and Functioning in a Clinical Sample Alex A. Cardoni, M.S.

18. Specificity of Effect of Quetiapine in Bipolar Depression Robert M. A. Hirschfeld, M.D.


Session 7. Diagnostic Issues

19. Screening for History of Physical, Emotional, and Sexual Abuse: How Do We Ask About Abuse? Brett D. Thombs, Ph.D.

20. Kennedy Axis V: The Next Step for Axis V? James A. Kennedy, M.D.

21. Dimensional Approaches to DSM and the Impact on Diagnostic Instruments Maritza Rubio-Stipec, Sc.D.


Session 8. Consultation-Liaison Psychiatry

22. Teaching of Psychiatry in Primary Care Residencies: Do Training Directors of Primary Care and Psychiatry See Eye to Eye? Hoyle Leigh, M.D.

23. Unrecognized Post-Traumatic Symptoms Triggered by Routine Hospital Care in Patients With Previous Trauma Histories Sarah Birmingham, M.D.

24. Is Asthma Severity Related to Current Major Depressive Episode and Generalized Anxiety Disorder? A Case-Control Study Claudia Meneses, M.D.


Session 9. Psychiatric Education

25. Psychiatric CMEs and Commercial Bias: Are New ACCME Standards Effective? Daniel J. Carlat, M.D.

26. Relationships Between Self-Assessment Skills, Test Performance, and Other Variables in Psychiatry Residents David J. Lynn, M.D.

27. Coaching Communication Using Standardized Patient Encounters: An Educational Research Study Paula Ravitz, M.D.


Session 10. Biological Psychiatry and Neuroscience

28. From Synapse to Psychotherapy: The Fascinating Evolution of Neuroscience Bernadette Grosjean, M.D.

29. Can Neurological Soft Signs Discriminate Between Four Axis-I Diagnostic Categories in the Prison Population? Seyed Mohammad Assadi, M.D.

30. An Association Study of a Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Zotepine Response of Inpatients With Acute Schizophrenia Ching-Hua Lin, M.D.


Session 11. Geriatric Psychiatry

31. The Influence of Dementia on the Treatment of Depression in Geriatric Inpatients John W. Goethe, M.D.

32. Overall Efficacy and Time to Response for Duloxetine 60 mg Once Daily Versus Placebo in Elderly Patients With MDD Joel Raskin, M.D.

33. Safety and Efficacy of Intra-Muscular Ziprasidone Treatment of Acute Psychotic Agitation in Elderly Patients With Schizophrenia Alex Aviv


Component Workshops

CW10. The Gift of Life: A Psychiatric Perspective on Living Hepatic Organ DonationAPA Council on Psychosomatic Medicine; Co-Chairpersons: Philip R. Muskin, M.D., Silvia Hafliger, M.D.

CW11. Toward a Better Understanding of Cultural Issues in Clinical Practice: Residents' Perspective of a Model Curriculum for Residency Training ProgramsAPA/AstraZeneca Minority Fellows; Chairperson: Angel A. Caraballo, M.D.

CW12. Ethnicity and Caregiving Across the Psychiatric SpectrumAPA Committee on Ethnic Minority Elderly; Co-Chairpersons: Iqbal Ahmed, M.D., Warachal E. Faison, M.D.

CW13. Sexuality and Its Impact on the HIV PandemicAPA Committee on HIV/AIDS; Chairperson: Marshall Forstein, M.D.

CW14. Psychiatric Ethics in the United States and Throughout the WorldAPA Ethics Committee; Co-Chairpersons: Spencer Eth, M.D., George Christodoulou, M.D.

CW15. Teaching the Working Alliance as a Core Process Across the PsychotherapiesAPA Committee on Psychotherapy by Psychiatrists; Chairperson: Eric M. Plakun, M.D.

CW16. Scales in the Clinical Practice of Geriatric PsychiatryAPA Committee on Access and Effectiveness of Psychiatric Services for the Elderly; Chairperson: Allan A. Anderson, M.D.

CW17. Winning the Fight for Mental Health Benefits: Partnering With EmployersAPA Committee on APA/Business Relationships; Chairperson: Dauda A. Griffin, M.D.

CW18. Culture as a Rationalization for Violence Against WomenAPA Committee on Family Violence and Abuse; Chairperson: Gail E. Robinson, M.D.

CW19. Facilitating Minorities to Excel in Academic PsychiatryAPA Assembly Committee of Representatives of Minority/Underrepresented Groups; Chairperson: Jagannathan Srinivasaraghavan, M.D.


Issue Workshops

IW16. Assessment of Capacity: Developments, DVDs, and Defense OrganizationsChairperson: M.E. Jan Wise, M.R.C. Psych.

IW17. Biopsychosocial and Spiritual Aspects of Treating Our Physician ColleaguesCo-Chairpersons: Monisha R. Vasa, M.D., Syed S. A. Naqvi, M.D.

IW18. Oral Boards Boot Camp: 2006Chairperson: Elyse D. Weiner, M.D.

IW19. The Other Desperate Housewives: Hidden Violence in the HomeChairperson: Susan J. Hatters-Friedman, M.D.

IW20. Treating First- and Second-Generation Immigrants With Psychotherapy During Residency TrainingChairperson: Anu A. Matorin, M.D.

IW21. Physician Heal Thyself: Workplace Burnout Among PsychiatristsCo-Chairpersons: John Sharkey, M.D., Steve Choong Kam Chong, M.D.

IW22. Psychotherapy Training and International Medical Graduates: The Influence of Cultural FactorsChairperson: Nyapati R. Rao, M.D.

IW23. Cognitive-Behavior Therapy for Psychosis: Basic Techniques for PsychiatristsChairperson: Shanaya Rathod, M.D.

IW24. Teaching Cognitive-Behavior Therapy to ResidentsCo-Chairpersons: Judith S. Beck, Ph.D., Donna M. Sudak, M.D.

IW25. Establishing a Women's Mental Health Program in an Academic or Private SettingCo-Chairpersons: Catherine A. Birndorf, M.D., Nehama Dresner, M.D.

IW26. Secrets in Family Therapy: To Tell or Not to TellCo-Chairpersons: Eva C. Ritvo, M.D., Michael Hughes, M.D.

IW27. Virtual Reality and Video Games in the Treatment of Mental Health Disorders and Addictions: An Evidence-Based AnalysisCo-Chairpersons: William Huang, M.D., Jeffery N. Wilkins, M.D.

IW28. Multidisciplinary Treatment of Adults With Asperger's Syndrome and Related Disorders: Lessons From the University of Pennsylvania Social Learning Disorders ProgramCo-Chairpersons: Anthony L. Rostain, M.D., Edward S. Brodkin, M.D.





New Research Young Investigators' Oral/Slide Sessions 2-4


CME Courses 51-57


Focus Live Session 3.Presenter: Jerald Kay, M.D., on Psychotherapy



L8. Heart Rate Variability and Psychiatry: Beyond Heart-Mind LinkKrishnamachari Srinivasan, M.D., International Lecture

L9. New Advances in Cognitive TherapyAaron T. Beck, M.D., APA's Adolf Meyer Award Lecture


Presidential Symposium 1.

The Public Mental Health System: Critical Issues APA Committee on Family Violenceand Abuse and Council on Social Issues and Public Psychiatry; Chairperson: Yvonne B. Ferguson, M.D.



S1. HIV Prevention Interventions With Psychiatric Patients From Around the World: Turning Research Into Practice

S2. Therapeutic Misconception in Clinical Research

S3. Migration and Mental Illness Around the WorldRoyal College of Psychiatrists

S4. Psychosocial Intervention and Cancer Survival

S5. Sexual Orientation and SportsInternational Society for Sport Psychiatry

S6. Insomnia: What Is It?

S7. The African Diaspora: Identifying and Eliminating Barriers to Mental Health

S8. Treatment Issues in Schizophrenia With Comorbid DisordersAmerican Association of Practicing Psychiatrists

S9. Rehabilitation in France, Canada, and the U.S.: From Science to Recovery: A Joint Meeting With the French Psychiatric Association: Vive la Difference

S10. Model Curricula on Religion and Spirituality for Psychiatry Residency Training Programs

S11. The Long-Term Care and Treatment of Elderly Patients With Bipolar DisorderAPA Council on Aging

S12. When Usual Treatments Fail: Augmentation Strategies for Refractory Schizophrenia

S13. Substance Use Disorders in the U.S.Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

S14. The Mid-Life Crisis as Interpreted in Film and Television

S15. First-Episode Schizophrenia: How Can We Improve Treatment Outcome?

S16. Adolescent Brain Development: Implications for Psychiatric TreatmentNational Institute on Drug Abuse

S17. Ethnicity, Age, and Gender as Factors in the Management of Anxiety and Depression

S18. Personality Disorders and Comorbidity: Predictive Factors and Clinical Implications

S19. Toward a Developmental Trauma Disorder

S20. Borderline Mothers and Infant Interactions: Chaotic Contingency

S21. Criminalization of Mental Illness: Getting In and Out in New YorkAmerican Association for Social Psychiatry

S22. Psychocultural Foundations of Political TerrorismAPA Council on Global Psychiatry and International Society of Political Psychology

S23. Science, Diagnoses, and the ClinicianWorld Psychiatric Association

S24. The Effective Psychotherapist: The Role of Common and Specific Factors

S25. Developing Strategies in Psychotherapy Research

Psychotherapy and Medication in Outcome Trials Michael E. Thase, M.D.

S26. Taking Science to Policy: Efforts to Reduce Harms Related to Alcohol MisuseCollaborative Session With the National Institute on Alcohol Abuse and Alcoholism

S27. Not Just Dopamine any More: Emerging Glutamatergic Therapies for Schizophrenia

S28. CANMAT Guidelines for the Management of Bipolar Disorder: An Effort Toward International Consensus

S29. Dementia in Patients With Down Syndrome: Risk Factors, Biomarkers, Diagnosis, and Treatment

S30. Geriatric Psychiatry: New Ideas and New Practices for the 21st Century

S31. Nancy Andreasen: Festschrift for Her 13 Years as Journal Editor

S32. A Spanish Language Update on the Assessment and Management of DepressionAmerican Society of Hispanic Psychiatry

S33. Recent Advances in Clinical Care and Clinical Research in BPD


Advances in PsychopharmacologyAlan F. Schatzberg, M.D.


New Research Poster Session 5


Convocation of Distinguished Fellows



L10. Connecting the Dots: The Interacting Problems of PovertyDavid K. Shipler, William C. Memorial Lecture



Industry-Supported Symposia

IS29. Pharmacotherapy of Psychotic and Mood Disorders With Co-Existing Medical IllnessSupported by AstraZeneca PharmaceuticalsFIG1

IS30. Helping Depressed Patients Achieve Remission: Advocacy for ImprovementSupported by Bristol-Myers Squibb Co.

IS31. Understanding and Managing the Transition of ADHD From Adolescence to Young Adulthood: The Maturation of the DisorderSupported by Shire US Inc.

IS32. The Cognition, Neurocircuitry, and Disability Interface: Bringing Evidence to PracticeSupported by Cephalon Inc.

IS33. Taking Control of Negative Symptoms: The Next Step for Improved Patient Outcomes in SchizophreniaSupported by Organon USA Inc. and Pfizer Inc.

Interactive Graphics


Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles